These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 8160668)

  • 1. Projecting future drug expenditures--1994.
    Santell JP
    Am J Hosp Pharm; 1994 Jan; 51(2):177-87. PubMed ID: 8160668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Projecting future drug expenditures--1993.
    Santell JP
    Am J Hosp Pharm; 1993 Jan; 50(1):71-7. PubMed ID: 8427283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Projecting future drug expenditures--1992.
    Ensor PA
    Am J Hosp Pharm; 1992 Jan; 49(1):140-5. PubMed ID: 1570858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Projecting future drug expenditures--1996.
    Santell JP
    Am J Health Syst Pharm; 1996 Jan; 53(2):139-50. PubMed ID: 8653479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Projecting future drug expenditures--1997.
    Mehl B; Santell JP
    Am J Health Syst Pharm; 1997 Jan; 54(2):153-61. PubMed ID: 9117803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Projecting future drug expenditures--2002.
    Shah ND; Vermeulen LC; Santell JP; Hunkler RJ; Hontz K
    Am J Health Syst Pharm; 2002 Jan; 59(2):131-42. PubMed ID: 11826567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Projecting future drug expenditures--1999.
    Mehl B; Santell JP
    Am J Health Syst Pharm; 1999 Jan; 56(1):31-9. PubMed ID: 10048877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization, price, and spending trends for antidepressants in the US Medicaid Program.
    Chen Y; Kelton CM; Jing Y; Guo JJ; Li X; Patel NC
    Res Social Adm Pharm; 2008 Sep; 4(3):244-57. PubMed ID: 18794035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Projecting future drug expenditures--1998.
    Mehl B; Santell JP
    Am J Health Syst Pharm; 1998 Jan; 55(2):127-36. PubMed ID: 9465976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing drug costs: the perception of managed care pharmacy directors.
    Litton LM; Sisk FA; Akins ME
    Am J Manag Care; 2000 Jul; 6(7):805-14. PubMed ID: 11067377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceuticals: pharmaceutical cost controls--2005. End of Year Issue Brief.
    Seay M; Varma P
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical prices continue to drive up supply costs.
    Hard R
    Hospitals; 1992 Mar; 66(5):49-50. PubMed ID: 1740289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Projecting future drug expenditures--2006.
    Hoffman JM; Shah ND; Vermeulen LC; Schumock GT; Grim P; Hunkler RJ; Hontz KM
    Am J Health Syst Pharm; 2006 Jan; 63(2):123-38. PubMed ID: 16390926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Battered bottom lines: the impact of eroding pharmaceutical discounts on health-care institutions.
    Palumbo FB; Schondelmeyer SW; Miller DW; Speedie SM
    Am J Hosp Pharm; 1992 May; 49(5):1177-85. PubMed ID: 1595750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Price regulation and generic competition in the pharmaceutical market.
    Dalen DM; Strøm S; Haabeth T
    Eur J Health Econ; 2006 Sep; 7(3):208-14. PubMed ID: 16841230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Projecting future drug expenditures--1995.
    Santell JP
    Am J Health Syst Pharm; 1995 Jan; 52(2):151-63. PubMed ID: 12879542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Projecting future drug expenditures--2000.
    Mehl B; Santell JP
    Am J Health Syst Pharm; 2000 Jan; 57(2):129-38. PubMed ID: 10688241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugmakers fight for good name. Stakes high, challenges many for providers who seek generic products.
    Becker C
    Mod Healthc; 2001 Aug; 31(35):28-33, 1. PubMed ID: 11550428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of multiple-source entry on price competition after patent expiration in the pharmaceutical industry.
    Suh DC; Manning WG; Schondelmeyer S; Hadsall RS
    Health Serv Res; 2000 Jun; 35(2):529-47. PubMed ID: 10857475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.